543 results on '"Heathcote, E. Jenny"'
Search Results
2. Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy
3. Hepatic Cell–Type Specific Gene Expression Better Predicts HCV Treatment Outcome Than IL28B Genotype
4. Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
5. Hepatology: Diagnosis and Clinical Management
6. Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches
7. Tenofovir and Entecavir Are the Most Effective Antiviral Agents for Chronic Hepatitis B: A Systematic Review and Bayesian Meta-analyses
8. Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy
9. Impact of Cirrhosis and Liver Transplant on Maternal Health During Labor and Delivery
10. Value of Autoantibody Analysis in the Differential Diagnosis of Chronic Cholestatic Liver Disease
11. Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C
12. Telaprevir for previously treated chronic HCV infection
13. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants
14. Hepatic fatty acid composition differs between chronic hepatitis C patients with and without steatosis
15. Successfully treated intractable pruritus with rifampin in a case of benign recurrent intrahepatic cholestasis
16. Symptomatic and Virological Response to Antiviral Therapy in Hepatitis C Associated with Extrahepatic Complications of Cryoglobulimia
17. Abnormal Intestinal Permeability in Primary Biliary Cirrhosis
18. Osteoporosis in Primary Biliary Cirrhosis: A Randomized Trial of the Efficacy and Feasibility of Estrogen/Progestin
19. Diagnosis and Management of Cholestatic Liver Disease
20. Liver Disease in Pregnant Women
21. Management of Complications of Portal Hypertension in Adults and Children: Variceal Hemorrhage
22. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
23. Peginterferon α-2a (40kD) [Pegasys®] Improves HR-QOL Outcomes Compared with Unmodified Interferon α-2a [Roferon®-A]: In Patients with Chronic Hepatitis C
24. Primary biliary cirrhosis
25. Contributors
26. Clinical Presentation
27. The Liver in Pregnancy
28. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
29. Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
30. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants
31. Hepatitis Caused by Other Viruses
32. Contributors
33. A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients
34. Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3
35. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis
36. Peginterferon alfa-2a in patients with chronic hepatitis C
37. Carriage of a Tumor Necrosis Factor Polymorphism Amplifies the Cytotoxic T-Lymphocyte Antigen 4 Attributed Risk of Primary Biliary Cirrhosis: Evidence for a Gene–Gene Interaction
38. Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
39. Preventative hepatology: minimising symptoms and optimising care
40. Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a
41. Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3
42. Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B
43. Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis with Telbivudine or Adefovir: A Randomized Trial
44. Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis
45. Treatment of hepatitis B: the next five years
46. Is rifampin a safe and effective treatment for pruritus caused by chronic cholestasis?
47. Successful Treatment with Peginterferon alfa-2b of HBeAg-positive HBV Non-Responders to Standard Interferon or Lamivudine
48. Hepatitis B e Antigen-Positive Chronic Hepatitis B: Natural History and Treatment
49. Long-term adefovir dipivoxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B: results after 5 years of therapy: 70
50. Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.